Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesTransplantation ConditioningAnemia, AplasticLeukemiaHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematologic NeoplasmsKidney TransplantationHematopoiesisTreatment OutcomeRecurrenceTime FactorsCombined Modality TherapyMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteRadiation ChimeraBone Marrow ExaminationRetrospective StudiesImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidBone Marrow NeoplasmsLymphoma, Non-HodgkinTransplantation ImmunologyGraft vs Host ReactionSurvival AnalysisImmunosuppressionStem Cell TransplantationLymphocyte DepletionAcute DiseaseLeukocyte TransfusionHeart TransplantationMyelodysplastic SyndromesT-LymphocytesSevere Combined ImmunodeficiencyFollow-Up StudiesChimeraColony-Forming Units AssayHLA AntigensLung TransplantationHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsProspective StudiesNuclear FamilyLymphomaCarmustineOrgan TransplantationSurvival RateCell DifferentiationGraft vs Tumor EffectPrognosisPancytopeniaOutpatient Clinics, HospitalGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsMultiple MyelomaBone ResorptionGranulocyte Colony-Stimulating FactorSpleenDisease-Free SurvivalMice, Inbred BALB CMelphalanFlow CytometryEtoposideFatal OutcomeHodgkin DiseaseCells, CulturedAntigens, CD34NeoplasmsInfectionMice, Knockout